期刊文献+

同型半胱氨酸、超敏C反应蛋白、纤维蛋白原与2型糖尿病大血管病变的相关性研究 被引量:20

Study on the Relationship of Homocysteine, High-sensitive C-reactive Protein, Fibrinogen with Macroangiopathy in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 【目的】探讨2型糖尿病合并大血管病变与血浆中的同型半胱氨酸、超敏C反应蛋白(hs—CRP)及纤维蛋白原的关系,并分析2型糖尿病大血管病变的相关危险因素。【方法】将2型糖尿病患者分为合并大血管病变组(n=75)与非血管病变组(n=138),设健康对照组20例,检测三组的血浆同型半胱氨酸、hs—CRP、纤维蛋白原水平。将相关因素进行logistic多因素回归分析。【结果】2型糖尿病合并大血管病变组患者血浆同型半胱氨酸、hs—CRP及纤维蛋白原水平显著高于无大血管病变组及对照组(均P〈0.01)。Logistic回归发现同型半胱氨酸、hs-CRP、纤维蛋白原等均是2型糖尿病合并大血管病变的独立危险因素(均P〈0.05)。【结论】血浆同型半胱氨酸、hs-CRP、纤维蛋白原水平与2型糖尿病大血管病变相关,炎症可能参与了糖尿病大血管病变过程。 [Objective]To explore the relationship of homocysteine, high-sensitive C-reactive protein(hs-CRP) and fibrinogen with macroangiopathy in patients with type 2 diabetes mellitus, and analyze its correlated risk factors. [Methods] Patients with type 2 diabetes mellitus were divided into macroangiopathy group( n = 75) and non-macroangiopathy group( n =138). Twenty healthy people were selected as control group. Plasma homocysteine, hs-CRP and fibrinogen were measured. Logistic multifactor regression analysis was performed. [Results]Plasma levels of homocysteine, hs-CRP and fibrinogen in macroangiopathy group were significantly higher than those in non-macroangiopathy group and control group(all P〈0.01). Logistic regression analysis showed that plasma levels of homocysteine, hs-CRP and fibrinogen were the main independent risk factors of macroangiopathy in patients with type 2 diabetes mellitus(all P〈0.05). [Conclusion] Plasma levels of homocysteine, hs-CRP and fibrinogen are related to macroangiopathy in type 2 diabetes mellitus. Inflammatory response may involve in the process of macroangiopathy in type 2 diabetes mellitus.
出处 《医学临床研究》 CAS 2012年第3期468-470,共3页 Journal of Clinical Research
关键词 糖尿病 非胰岛素依赖型 C反应蛋白质 半胱氨酸 纤维蛋白原 Diabetes mellitus,non-insulin-dependent C-reactive protein cysteine fibrinogen
  • 相关文献

参考文献12

  • 1Aléssio AC,Santos CX,Debbas V. Evaluation of mild hyperhomocysteinemia during the development of atherosclerosis in apolipoprotein E-deficient and normal mice[J].Experimental and Molecular Pathology,2011,(01):45-50.
  • 2Zhou J,Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis:Causal relationship and potential mechanisms[J].Biofactors,2009,(02):120-129.doi:10.1002/biof.17.
  • 3Zhang D,Jiang X,Fang P. Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice[J].Circulation,2009,(19):1893-1902.
  • 4Nakbi A,Koubaa N,Ben Hamda K. Association between oxidative stress parameters and inflammation markers according to the gravity of the acute coronary syndrome[J].Tunisie Medicale,2011,(07):621-626.
  • 5Hofmann MA,Lalla E,Lu Y. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model[J].Journal of Clinical Investigation,2001,(06):675-683.
  • 6Ezgü F,Tümer L,Ozbay F. Homocysteine,fibrinogen and anti-ox-LDL antibody levels as markers of atherosclerosis in prepubertal obese children[J].Journal of Pediatric Endocrinology and Metabolism,2009,(10):915-920.
  • 7Chai HT,Chen YL,Chung SY. Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study[J].INTERNATIONAL HEART JOURNAL,2011,(05):280-285.
  • 8Antoniades C,Antonopoulos AS,Tousoulis D. Homocysteine and coronary atherosclerosis:from folate fortification to the recent clinical trials[J].European Heart Journal,2009,(01):6-15.doi:10.1093/eurheartj/ehn515.
  • 9Sata M. Role of chronic inflammation in the pathogenesis of atherosclerosis[J].Nihon Yakurigaku Zasshi,2011,(05):182-186.
  • 10Libby P,Okamoto Y,Rocha VZ. Inflammation in atherosclerosis:transition from theory to practice[J].Circulation,2010,(02):213-220.

同被引文献140

引证文献20

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部